Testing for Spread of Stomach Cancer to Abdominal Cavity
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 21-001141
Sponsor Protocol Number: 21-001141
About this study
The purpose of this study is to establish a clinical useful gene expression panel for detecting and predicting peritoneal relapse and survival to address the unmet clinical need for a simple and accurate staging of the peritoneum in gastric cancer.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult patient, ≥ 18 years of age.
- Undergoing diagnostic laparoscopy and peritoneal washings for staging of gastric adenocarcinoma per normal clinical indications.
- Patients included will be those who are undergoing this procedure as part of their clinical work-up and will be identified by study staff and the clinical providers.
- All patients will undergo staging imaging including high quality CT scan with contrast and/or PET CT or PER MRI imaging as standard of care.
- Patients will undergo diagnostic laparoscopy with traditional peritoneal cytology with H&E as well as IHC evaluation performed as standard clinical care. If a single patient undergoes multiple diagnostic laparoscopies with peritoneal cytology for clinical purposes excess fluid can be collected from each patient.
Exclusion Criteria:
- Any patient with insufficient excess peritoneal washing fluid will be excluded.
Eligibility last updated [date of initial abstraction or last Mod]. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Travis Grotz, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available